Pfizer and BioNTech Release New Results Of Phase 3 Study Concluding That Their Vaccine is 95% Effective

Photo by CDC on Unsplash

In the global race to develop the most effective Covid-19 vaccine, Pfizer and BioNTech are determined to establish their position as top candidate.

Phase 3 results involving 43,000 participants have concluded that the Pfizer and BioNTech vaccine is 95% effective within 28 days of the first dose.

The duo also addressed the issue of temperature requirements regarding vaccine transportation, stating that they have “developed specially designed, temperature-controlled thermal shippers utilizing dry ice to maintain temperature conditions of -70°C±10°C”.

About Steven Psaradakis 67 Articles
As a science graduate interested in truth and wellbeing, Steven's writing explores current affairs from a measured and logical perspective. Steven's work has been shared in Dialogue & Discourse, The Innovation, and Data Driven Investor.